Hotel Dieu

Nantes 44903

0 studies enrolling now · 8 studies all time

What they study most

Aspergillosis, Crohn Disease, Diffuse Large B-cell Lymphoma, HIV Infections, Invasive Fungal Infection, Invasive Fungal Infections, Lipodystrophy, Melanoma, Metastases, Multiple Myeloma, Psoriatic Arthritis

Studies at this site

• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab — Stopped early
• Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi — Completed
• Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis — Completed
• TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy — Completed
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) — Completed
• Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) — Completed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed